2024-03-29T10:01:50Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_247C151A7AD3
2024-03-23T02:00:47Z
serval:BIB_247C151A7AD3
Ex vivo detectable activation of Melan-A-specific T cells correlating with inflammatory skin reactions in melanoma patients vaccinated with peptides in IFA.
15149168
LiƩnard
D.
author
Rimoldi
D.
author
Marchand
M.
author
Dietrich
P.Y.
author
van Baren
N.
author
Geldhof
C.
author
Batard
P.
author
Guillaume
P.
author
Ayyoub
M.
author
Pittet
M.J.
author
Zippelius
A.
author
Fleischhauer
K.
author
Lejeune
F.
author
Cerottini
J.C.
author
Romero
P.
author
Speiser
D.E.
author
article
2004
Cancer Immunity
1424-9634
1424-9634
journal
4
4
Adolescent
Adult
Aged
Antigens, Neoplasm
CD8-Positive T-Lymphocytes/immunology
Cancer Vaccines/immunology
Cancer Vaccines/toxicity
Dermatitis/etiology
Disease Progression
Female
Freund's Adjuvant/therapeutic use
Humans
Lipids/therapeutic use
Lymphocyte Activation
MART-1 Antigen
Male
Melanoma/diagnosis
Melanoma/immunology
Middle Aged
Monitoring, Immunologic
Neoplasm Proteins/immunology
Peptides/immunology
Peptides/therapeutic use
Viral Matrix Proteins/immunology
eng
60_published
Publication types: Clinical Trial ; Clinical Trial, Phase I ; Clinical Trial, Phase II ; Controlled Clinical Trial ; Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: epublish